Literature DB >> 15765780

Isolation of mesenchymal stem cells from cryopreserved human umbilical cord blood.

Myoung Woo Lee1, Mal Sook Yang, Joon Seong Park, Hugh C Kim, Young Jin Kim, Jeongeun Choi.   

Abstract

Umbilical cord blood (UCB) is well known to be a rich source of hematopoietic stem cells with practical and ethical advantages. Because mesenchymal stem cells (MSCs) from bone marrow have been regarded as good materials for cell/gene therapy as well as for tissue engineering because of their multidifferentiation potential, a number of trials have been undertaken to isolate MSCs from UCB. However, the results have been controversial, and little has become known about the effect of cryopreservation on the isolation of these stem cells. In this study, we examined the ability of cryopreserved UCB-derived cells to produce MSCs. Various culture conditions, including the seeding concentrations of cells and the media used, were investigated. We were able to obtain adherent cell populations after 3 to 5 weeks in our culture conditions from UCB-derived mononuclear cell fractions that had undergone cryopreservation for 0.1 to 5 years. These cells exhibited a fibroblast-like morphology and typical mesenchymal-like immunophenotypes. The results indicate that cryopreserved human UCB fractions can be used as an alternative source of MSCs for experimental and clinical applications as well as for tissue engineering.

Entities:  

Mesh:

Year:  2005        PMID: 15765780     DOI: 10.1532/ijh97.a10404

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  13 in total

1.  Mesenchymal progenitor cells in human umbilical cord blood.

Authors:  A Erices; P Conget; J J Minguell
Journal:  Br J Haematol       Date:  2000-04       Impact factor: 6.998

Review 2.  Mesenchymal stem cells.

Authors:  J J Minguell; A Erices; P Conget
Journal:  Exp Biol Med (Maywood)       Date:  2001-06

Review 3.  Genetics and the specificity of the aging process.

Authors:  Siegfried Hekimi; Leonard Guarente
Journal:  Science       Date:  2003-02-28       Impact factor: 47.728

4.  Isolation of multipotent mesenchymal stem cells from umbilical cord blood.

Authors:  Oscar K Lee; Tom K Kuo; Wei-Ming Chen; Kuan-Der Lee; Shie-Liang Hsieh; Tain-Hsiung Chen
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

5.  Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord.

Authors:  Yuri A Romanov; Veronika A Svintsitskaya; Vladimir N Smirnov
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

6.  Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not.

Authors:  Sarah A Wexler; Craig Donaldson; Patricia Denning-Kendall; Claire Rice; Ben Bradley; Jill M Hows
Journal:  Br J Haematol       Date:  2003-04       Impact factor: 6.998

7.  Tumor suppressor genes: the puzzle and the promise.

Authors:  R Sager
Journal:  Science       Date:  1989-12-15       Impact factor: 47.728

8.  Characterization of cells with osteogenic potential from human marrow.

Authors:  S E Haynesworth; J Goshima; V M Goldberg; A I Caplan
Journal:  Bone       Date:  1992       Impact factor: 4.398

Review 9.  Control of fibroblast senescence and activation of programmed cell death.

Authors:  E Wang; M J Lee; S Pandey
Journal:  J Cell Biochem       Date:  1994-04       Impact factor: 4.429

10.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

View more
  27 in total

1.  Schwann-like cells can be induction from human nestin-positive amniotic fluid mesenchymal stem cells.

Authors:  Tai-Mao Jiang; Zhi-Jun Yang; Chui-Ze Kong; Hong-Tian Zhang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-07-22       Impact factor: 2.416

2.  Differentiation of cryopreserved human umbilical cord blood-derived stromal cells into cells with an oligodendrocyte phenotype.

Authors:  Yong-Chun Luo; Hong-Tian Zhang; Hao-Yu Cheng; Zhi-Jun Yang; Yi-Wu Dai; Ru-Xiang Xu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-04-27       Impact factor: 2.416

3.  Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art.

Authors:  Arianna Malgieri; Eugenia Kantzari; Maria Patrizia Patrizi; Stefano Gambardella
Journal:  Int J Clin Exp Med       Date:  2010-09-07

Review 4.  Controlled differentiation of stem cells.

Authors:  Nathaniel S Hwang; Shyni Varghese; Jennifer Elisseeff
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

Review 5.  Stem cells for spine surgery.

Authors:  Joshua Schroeder; Janina Kueper; Kaplan Leon; Meir Liebergall
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

6.  Enrichment and characterization of human dermal stem/progenitor cells by intracellular granularity.

Authors:  Joong Hyun Shim; Tae Ryong Lee; Dong Wook Shin
Journal:  Stem Cells Dev       Date:  2013-01-22       Impact factor: 3.272

7.  A preliminary study of mesenchymal stem cell-like cells derived from murine corneal stroma.

Authors:  Jian-Min Lu; Zhong-You Zhou; Xiao-Rong Zhang; Xiao-Lei Li; Hui-Fang Wang; Xiu-Jun Song
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09       Impact factor: 3.117

Review 8.  Mesenchymal stem cells in the treatment of spinal cord injuries: A review.

Authors:  Venkata Ramesh Dasari; Krishna Kumar Veeravalli; Dzung H Dinh
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

Review 9.  Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics.

Authors:  Ryan M McAdams; Sandra E Juul
Journal:  Clin Perinatol       Date:  2016-06-22       Impact factor: 3.430

10.  Advantages of Sheep Infrapatellar Fat Pad Adipose Tissue Derived Stem Cells in Tissue Engineering.

Authors:  Parviz Vahedi; Jafar Soleimanirad; Leila Roshangar; Hajar Shafaei; Seyedhosein Jarolmasjed; Hojjatollah Nozad Charoudeh
Journal:  Adv Pharm Bull       Date:  2016-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.